Global Animal Anti-infectives Market Size By Type (Injection, Unguent), By Application (Livestock, Pets), By Region, And Segment Forecasts, 2023 to 2032

The Global Animal Anti-infectives Market was valued at USD 18.4 billion in 2023 and is projected to reach USD 28.7 billion by 2031, growing at a CAGR of 5.8% from 2023 to 2031. The rising prevalence of infectious diseases in livestock and companion animals, coupled with increasing awareness about animal health, is driving the market forward. Anti-infectives such as antibiotics, antivirals, antifungals, and antiparasitics are vital in preventing and treating a range of infections that compromise animal productivity and welfare. Regulatory support for veterinary healthcare and the expansion of the animal husbandry sector, particularly in emerging markets, further bolster the demand for anti-infectives globally.

Drivers

1. Rising Incidence of Zoonotic and Infectious Diseases:

The growing emergence of bacterial, viral, and parasitic infections in animals is significantly increasing the demand for effective anti-infective treatments.

2. Expansion of the Livestock and Poultry Industry:

With escalating demand for animal-based food products worldwide, maintaining animal health through preventive and therapeutic solutions has become a priority.

3. Technological Advancements in Veterinary Pharmaceuticals:

Innovations such as targeted drug delivery, combination therapies, and long-acting injectables are enhancing treatment outcomes and fostering market growth.

Restraints

1. Regulatory Restrictions and Antimicrobial Resistance (AMR):

Strict regulations on antibiotic usage and rising concerns about AMR are limiting indiscriminate use and challenging manufacturers to innovate.

2. High Costs of Drug Development:

The substantial R&D investment and lengthy approval processes required for veterinary drugs can be a barrier for new entrants and small-scale producers.

Opportunity

1. Growth in Companion Animal Ownership:

Increasing pet adoption and rising expenditure on pet health are creating new opportunities for anti-infective products, especially in urban markets.

2. Emerging Markets Expansion:

Regions like Asia-Pacific and Latin America are witnessing rapid growth in animal agriculture and veterinary infrastructure, presenting lucrative prospects for manufacturers.

Market by System Type Insights

The Antibiotics segment dominated the global animal anti-infectives market in 2023. Despite regulatory scrutiny, antibiotics remain essential for treating a wide range of bacterial infections in livestock and pets. Their affordability and broad-spectrum efficacy contribute to widespread adoption. However, the Antiparasitics segment is expected to grow at the fastest pace, driven by increasing parasitic resistance and higher prevalence in tropical climates.

Market by End-use Insights

The Livestock segment emerged as the largest revenue generator in 2023, accounting for over 60% of the market share. This includes cattle, poultry, and swine, which are most susceptible to infectious diseases due to intensive farming practices. Meanwhile, the Companion Animals segment is rapidly gaining momentum, supported by greater emphasis on pet wellness and increased veterinary consultations in urban households.

Market by Regional Insights

North America led the market in 2023, supported by robust veterinary healthcare infrastructure, high animal healthcare expenditure, and the presence of leading pharmaceutical companies. Asia-Pacific is expected to register the highest growth rate during the forecast period due to expanding livestock production, government vaccination initiatives, and increasing pet ownership in countries like China, India, and Indonesia.

Competitive Scenario

Key players in the Global Animal Anti-infectives Market include:

Zoetis Inc.

Merck Animal Health

Boehringer Ingelheim

Elanco Animal Health

Ceva Santé Animale

Vetoquinol

Norbrook

Virbac

Dechra Pharmaceuticals

Phibro Animal Health

These companies are focused on product innovation, strategic partnerships, acquisitions, and geographic expansion. Recent developments include:

2023: Zoetis launched a new long-acting antiparasitic injectable tailored for tropical climates.

2024: Boehringer Ingelheim expanded its production facility in Latin America to meet growing demand for animal antibiotics.

2025: Elanco partnered with a biotechnology firm to develop novel antivirals for emerging infectious diseases in pets.

Scope of Work – Global Animal Anti-infectives Market

FAQs

1. What is the current market size of the Global Animal Anti-infectives Market?

The market was valued at USD 18.4 billion in 2023.

2. What is the major growth driver of the Global Animal Anti-infectives Market?

Rising prevalence of infectious diseases in animals and growing demand for livestock productivity.

3. Which is the largest region during the forecast period in the Global Animal Anti-infectives Market?

North America holds the largest market share.

4. Which segment accounted for the largest market share in the Global Animal Anti-infectives Market?

The Livestock segment dominated the market in 2023.

5. Who are the key market players in the Global Animal Anti-infectives Market?

Key players include Zoetis Inc., Merck Animal Health, Boehringer Ingelheim, Elanco Animal Health, and Ceva Santé Animale.